Lymphoma caused by intestinal microbiota

International Journal of Environmental Research and Public Health

Volumn 11, Issue 9, 2014, Pages 9038-9049

  Yamamoto, Mitsuko L ^a   Schiestl, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Inflammation; Intestinal microbiota; Lymphoma; Prevention

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17;

BIOTA; CANCER; DISEASE PREVALENCE; DISEASE TREATMENT; IMMUNE SYSTEM; PATHOGEN; PUBLIC HEALTH;

CANCER MODEL; CANCER PROGNOSIS; CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; EXPERIMENTAL ANIMAL; GENETIC MODEL; GERMFREE ANIMAL; HELICOBACTER; HELICOBACTER FELIS; HELICOBACTER HELMANII; HELICOBACTER PYLORI; HISTORY OF MEDICINE; HUMAN; IMMUNOPATHOLOGY; INTESTINE FLORA; LACTOBACILLUS JOHNSONII; LIFESPAN; LYMPHOMA; MICROBIOME; MICROBIOTA INDUCED LYMPHOMAGENESIS; MOUSE; MUCOSAL ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; ORGANISMAL INTERACTION; OXIDATIVE STRESS; PHENOTYPE; REVIEW; SPECIES COMPOSITION; ANIMAL; BACTERIAL PHENOMENA AND FUNCTIONS; DISEASE MODEL; INTESTINE; MICROBIOLOGY; MICROFLORA;

ANIMALS; BACTERIAL PHYSIOLOGICAL PHENOMENA; DISEASE MODELS, ANIMAL; HUMANS; INTESTINES; LYMPHOMA; MICROBIOTA;

EID: 84908072661     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110909038     Document Type: Review

References (97)

1. Compare, D.; Nardone, G. Contribution of gut microbiota to colonic and extracolonic cancer development. Dig. Dis. 2011, 29, 554-561.
2. Westbrook, A. M.; Wei, B.; Braun, J.; Schiestl, R. H. Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res. 2009, 69, 4827-4834.
3. Westbrook, A. M.; Wei, B.; Braun, J.; Schiestl, R. H. Intestinal inflammation induces genotoxicity to extraintestinal tissues and cell types in mice. Int. J. Cancer 2011, 129, 1815-1825.
4. Umesaki, Y.; Setoyama, H. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect. 2000, 2, 1343-1351.
5. Tlaskalova-Hogenova, H.; Stepankova, R.; Kozakova, H.; Hudcovic, T.; Vannucci, L.; Tuckova, L.; Rossmann, P.; Hrncir, T.; Kverka, M.; Zakostelska, Z.; et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: Contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol. Immunol. 2011, 8, 110-120.
6. Faith, J. J.; Rey, F. E.; O'Donnell, D.; Karlsson, M.; Mcnulty, N. R.; Kallstrom, G.; Goodman, A. L.; Gordon, J. I. Creating and characterizing communities of human gut microbes in gnotobiotic mice. ISME J. 2010, 4, 1094-1098.
7. Backhed, F.; Ding, H.; Wang, T.; Hooper, L. V.; Koh, G. Y.; Nagy, A.; Semenkovich, C. F.; Gordon, J. I. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad. Sci. USA 2004, 101, 15718-15723.
8. Yi, P.; Li, L. The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host. Vet. Microbiol. 2012, 157, 1-7.
9. Bultman, S. J. Emerging roles of the microbiome in cancer. Carcinogenesis 2014, 35, 249-255.
10. Arthur, J. C.; Perez-Chanona, E.; Muhlbauer, M.; Tomkovich, S.; Uronis, J. M.; Fan, T.-J.; Campbell, B. J.; Abujamel, T.; Dogan, B.; Rogers, A. B. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338, 120-123.
11. Iliev, I. D.; Funari, V. A.; Taylor, K. D.; Nguyen, Q.; Reyes, C. N.; Strom, S. P.; Brown, J.; Becker, A. A.; Fleshner, P. R.; Dubinsky, M. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012, 336, 1314-1317.
12. Chassaing, B.; Aitken, J. D.; Gewirtz, A. T.; Vijay-Kumar, M. Gut microbiota drives metabolic disease in immunologically altered mice. Adv. Immunol. 2012, 116, 93-112.
13. Erdman, S. E.; Poutahidis, T.; Tomczak, M.; Rogers, A. B.; Cormier, K.; Plank, B.; Horwitza, B. H.; Fox, J. G. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 2003, 162, 691-702.
14. Haseman, J. K.; Hailey, J. R.; Morris, R. W. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: A National Toxicology Program update. Toxicol. Pathol. 1998, 26, 428-441.
15. Haseman, J. K.; Huff, J. E.; Rao, G. N.; Eustis, S. L. Sources of variability in rodent carcinogenicity studies. Fundam Appl. Toxicol. 1989, 12, 793-804.
16. Rao, G. N.; Haseman, J. K.; Grumbein, S.; Crawford, D. D.; Eustis, S. L. Growth, body weight, survival, and tumor trends in F344/N rats during an eleven-year period. Toxicol. Pathol. 1990, 18, 61-70.
17. Walburg, H. E., Jr.; Cosgrove, G. E.; Upton, A. C. Influence of microbial environment on development of myeloid leukemia in x-irradiated RFM mice. Int. J. Cancer. 1968, 3, 150-154.
18. Reliene, R.; Schiestl, R. H. Differences in animal housing facilities and diet may affect study outcomes-a plea for inclusion of such information in publications. DNA Repair 2006, 5, 651-653.
19. Fanning, S. L.; Appel, M. Y.; Berger, S. A.; Korngold, R.; Friedman, T. M. The immunological impact of genetic drift in the B10. BR congenic inbred mouse strain. J. Immunol. 2009, 183, 4261-4272.
20. Stevens, J. C.; Banks, G. T.; Festing, M. F.; Fisher, E. M. Quiet mutations in inbred strains of mice. Trends Mol. Med. 2007, 13, 512-519.
21. Rao, G. N.; Crockett, P. W. Effect of diet and housing on growth, body weight, survival and tumor incidences of B6C3F1 mice in chronic studies. Toxicol. Pathol. 2003, 31, 243-250.
22. Bleich, A.; Hansen, A. K. Time to include the gut microbiota in the hygienic standardisation of laboratory rodents. Comp. Immunol. Microbiol. Infect. Dis. 2012, 35, 81-92.
23. Yamamoto, M. L.; Maier, I.; Dang, A. T.; Berry, D.; Liu, J.; Ruegger, P. M.; Yang, J.-I.; Soto, P. A.; Presley, L. L.; Reliene, R.; et al. Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity. Cancer Res. 2013, 73, 4222-4232.
24. Saito, Y.; Suzuki, H.; Tsugawa, H.; Imaeda, H.; Matsuzaki, J.; Hirata, K.; Hosoe, N.; Nakamura, M.; Mukai, M.; Saito, H.; et al. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One 2012, 7, doi: 10. 1371/journal. pone. 0047396.
25. Isaacson, P. G.; Du, M. Q. MALT lymphoma: from morphology to molecules. Nat. Rev. Cancer. 2004, 4, 644-653.
26. Wotherspoon, A. C.; Ortiz-Hidalgo, C.; Falzon, M. R.; Isaacson, P. G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991, 338, 1175-1176.
27. Bayerdorffer, E.; Rudolph, B.; Neubauer, A.; Thiede, C.; Lehn, N.; Eidt, S.; Stolte, M.; Malt Lyphoma Study Group. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995, 345, 1591-1594.
28. Enno, A.; O'Rourke, J. L.; Howlett, C. R.; Jack, A.; Dixon, M. F.; Lee, A. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am. J. Pathol. 1995, 147, 217-222.
29. Hirayama, F.; Takagi, S.; Kusuhara, H.; Iwao, E.; Yokoyama, Y.; Ikeda, Y. Induction of gastric ulcer and intestinal metaplasia in mongolian gerbils infected with Helicobacter pylori. J. Gastroenterol. 1996, 31, 755-757.
30. Mueller, A.; O'Rourke, J.; Grimm, J.; Guillemin, K.; Dixon, M. F.; Lee, A.; Falkow, S. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc. Natl. Acad. Sci. USA 2003, 100, 1292-1297.
31. O'Rourke, J. L. Gene expression profiling in Helicobacter-induced MALT lymphoma with reference to antigen drive and protective immunization. J. Gastroenterol. Hepatol. 2008, 23, 151-156.
32. Suzuki, A.; Kobayashi, M.; Matsuda, K.; Matsumoto, T.; Kawakubo, M.; Kumazawa, S.; Koide, N.; Miyagawa, S.; Ota, H. Induction of high endothelial venule-like vessels expressing GlcNAc6ST-1-mediated L-selectin ligand carbohydrate and mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in a mouse model of "Candidatus Helicobacter heilmannii"-induced gastritis and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Helicobacter 2010, 15, 538-548.
33. O'Rourke, J. L.; Dixon, M. F.; Jack, A.; Enno, A.; Lee, A. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of "Helicobacter heilmannii" infection. J. Pathol. 2004, 203, 896-903.
34. Nakamura, M.; Murayama, S. Y.; Serizawa, H.; Sekiya, Y.; Eguchi, M.; Takahashi, S.; Nishikawa, K.; Takahashi, T.; Matsumoto, T.; Yamada, H.; et al. "Candidatus Helicobacter heilmannii" from a cynomolgus monkey induces gastric mucosa-associated lymphoid tissue lymphomas in C57BL/6 mice. Infect. Immun. 2007, 75, 1214-1222.
35. Suarez, F.; Lortholary, O.; Hermine, O.; Lecuit, M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006, 107, 3034-3044.
36. Gold, J. S.; Bayar, S.; Salem, R. R. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch. Surg. 2004, 139, 760-765.
37. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell 2000, 100, 57-70.
38. Newman, J. V.; Kosaka, T.; Sheppard, B. J.; Fox, J. G.; Schauer, D. B. Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J. Infect. Dis. 2001, 184, 227-230.
39. Wu, S.; Rhee, K. J.; Albesiano, E.; Rabizadeh, S.; Wu, X.; Yen, H.-R.; Huso, D. L.; Brancati, F. L.; Wick, E.; McAllister, F.; et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 2009, 15, 1016-1022.
40. Diwan, B. A.; Ward, J. M.; Ramljak, D.; Anderson, L. M. Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice. Toxicol. Pathol. 1997, 25, 597-605.
41. Barlow, C.; Hirotsune, S.; Paylor, R.; Liyanage, M.; Eckhaus, M.; Collins, F.; Shiloh, Y.; Crawley, J. N.; Ried, T.; Tagle, D.; et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86, 159-171.
42. Reliene, R.; Schiestl, R. H. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair 2006, 5, 852-859.
43. Fujiwara, D.; Wei, B.; Presley, L. L.; Brewer, S.; McPherson, M.; Lewinki, M. A.; Borneman, J.; Braun, J. Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. J. Immunol. 2008, 180, 5843-5852.
44. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8, 411-420.
45. MacDonald, T. T.; Gordon, J. N. Bacterial regulation of intestinal immune responses. Gastroenterol. Clin. North Am. 2005, 34, 401-412, vii-viii.
46. Reddy, B. S.; Mangat, S.; Weisburger, J. H.; Wynder, E. L. Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial beta-glucuronidase activity in F344 rats. Cancer Res. 1977, 37, 3533-3536.
47. Takada, H.; Hirooka, T.; Hiramatsu, Y.; Yamamoto, M. Effect of beta-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res. 1982, 42, 331-334.
48. Knasmuller, S.; Steinkellner, H.; Hirschl, A. M.; Rabot, S.; Nobis, E. C.; Kassie, F. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat. Res. 2001, 480-481, 129-138.
49. Kassie, F.; Rabot, S.; Kundi, M.; Chabicovsky, M.; Qin, H. M.; Knasmuller, S. Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3-methylimidazo [4, 5-f]quinoline. Carcinogenesis 2001, 22, 1721-1725.
50. Hayatsu, H.; Hayatsu, T. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett. 1993, 73, 173-179.
51. Kullisaar, T.; Songisepp, E.; Mikelsaar, M.; Zilmer, K.; Vihalemm, T.; Zilmer, M. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br. J. Nutr. 2003, 90, 449-456.
52. Blaser, M. J.; Atherton, J. C. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 2004, 113, 321-333.
53. Arabski, M.; Klupinska, G.; Chojnacki, J.; Kazmierczak, P.; Wisniewska-Jarosinska, M.; Drzewoski, J.; Blasiak, J. DNA damage and repair in Helicobacter pylori-infected gastric mucosa cells. Mutat. Res. 2005, 570, 129-135.
54. Smoot, D. T.; Elliott, T. B.; Verspaget, H. W.; Jones, D.; Allen, C. R.; Vernon, K. G.; Bremner, T.; Kidd, C. R.; Kim, K. S.; Groupman, J. D.; et al. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis 2000, 21, 2091-2095.
55. Klinder, A.; Forster, A.,.; Caderni, G.; Femia, A. P.; Pool-Zobel, B. L. Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr. Cancer 2004, 49, 144-155.
56. Vieira, J. M.; Seabra, S. H.; Vallim, D. C.; Americo, M. A.; Fracallanza, S. E. L.; Vommaro, R. C.; Domingues, R. M. C. P. Bacteroides fragilis induce necrosis on mice peritoneal macrophages: In vitro and in vivo assays. Biochem. Biophys. Res. Commun. 2009, 387, 627-632.
57. Kumar, A.; Wu, H.; Collier-Hyams, L. S.; Hansen, J. M.; Li, T.; Yamoah, K.; Pan, Z.-Q.; Jones, D. P.; Neish, A. S. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 2007, 26, 4457-4466.
58. Ames, B. N.; Shigenaga, M. K.; Hagen, T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 1993, 90, 7915-7922.
59. Cerutti, P.; Ghosh, R.; Oya, Y.; Amstad, P. The role of the cellular antioxidant defense in oxidant carcinogenesis. Environ. Health Perspect. 1994, 102, 123-129.
60. Coussens, L. M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
61. Banks, P. M. Gastrointestinal lymphoproliferative disorders. Histopathology 2007, 50, 42-54.
62. Bende, R. J.; Aarts, W. M.; Riedl, R. G.; de Jong, D.; Pals, S. T.; van Noesel, C. J. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 2005, 201, 1229-1241.
63. Shanahan, F. Nutrient tasting and signaling mechanisms in the gut V. Mechanisms of immunologic sensation of intestinal contents. Am. J. Physiol. Gastrointest Liver Physiol. 2000, 278, 191-196.
64. Arimochi, H.; Kinouchi, T.; Kataoka, K.; Kuwahara, T.; Ohnishi, Y. Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem. Biophys. Res. Commun. 1997, 238, 753-757.
65. Hirayama, K.; Rafter, J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000, 2, 681-686.
66. Cebra, J. J. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 1999, 69, 1046-1051.
67. Hooper, L. V.; Midtvedt, T.; Gordon, J. I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22, 283-307.
68. Hooper, L. V.; Gordon, J. I. Commensal host-bacterial relationships in the gut. Science 2001, 292, 1115-1118.
69. Wei, B.; Su, T. T.; Dalwadi, H.; Stephan, R. P.; Fujiwara, D.; Huang, T. T.; Brewer, S.; Chen, L.; Arditi, M.; Borneman, J.; et al. Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. Eur. J. Immunol. 2008, 38, 3411-3425.
70. Wei, B.; Wingender, G.; Fujiwara, D.; Chen, D. Y.; McPherson, M.; Brewer, S.; Borneman, J.; Kronenberg, M.; Braun, J. Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J. Immunol. 2010, 184, 1218-1226.
71. Huang, T.; Wei, B.; Velazquez, P.; Borneman, J.; Braun, J. Commensal microbiota alter the abundance and TCR responsiveness of splenic naive CD4+ T lymphocytes. Clin. Immunol. 2005, 117, 221-230.
72. Gaboriau-Routhiau, V.; Rakotobe, S.; Lecuyer, E.; Mulder, I.; Lan, A.; Bridonneau, C.; Rochet, V.; Pisi, A.; De Paepe, M.; Brandi, G.; et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31, 677-689.
73. Mazmanian, S. K.; Liu, C. H.; Tzianabos, A. O.; Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122, 107-118.
74. Sonnenburg, J. L.; Chen, C. T.; Gordon, J. I. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 2006, 4, doi: 10. 1371/journal. pbio. 0040413.
75. Vannucci, L.; Stepankova, R.; Kozakova, H.; Fiserova, A.; Rossmann, P.; Tlaskalova-Hogenova, H. Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int. J. Oncol. 2008, 32, 609-617.
76. Ishikawa, H.; Akedo, I.; Otani, T.; Takeyama, I.; Ishiguro, S.; Miyaoka, E.; Sobue, T.; Kakizoe, T. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer. 2005, 116, 762-767.
77. Kim, J. E.; Kim, J. Y.; Lee, K. W.; Lee, H. J. Cancer chemopreventive effects of lactic acid bacteria. J. Microbiol. Biotechnol. 2007, 17, 1227-1235.
78. Kingma, S. D.; Li, N.; Sun, F.; Valladares, R. B.; Neu, J.; Lorca, G. L. Lactobacillus johnsonii N6. 2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. J. Nutr. 2011, 141, 1023-1028.
79. Valladares, R.; Sankar, D.; Li, N.; Williams, E.; Lai, K.-K.; Abdelgeliel, A. S.; Gonzalez, C. F.; Wasserfall, C. H.; Larkin, J., III; Schatz, D.; et al. Lactobacillus johnsonii N6. 2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 5, doi: 10. 1371/journal. pone. 0010507.
80. Matsuzaki, T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 1998, 41, 133-140.
81. Kato, I.; Endo, K.; Yokokura, T. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 1994, 16, 29-36.
82. Kato, I.; Yokokura, T.; Mutai, M. Macrophage activation by Lactobacillus casei in mice. Microbiol. Immunol. 1983, 27, 611-618.
83. Rafter, J. Probiotics and colon cancer. Best Pract Res Clin Gastroenterol. 2003, 17, 849-859.
84. Smith, P. M.; Howitt, M. R.; Panikov, N.; Michaud, M.; Gallini, C. A.; Bohlooly Y, M.; Glickman, J. N.; Garrett, W. S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341, 569-573.
85. Arpaia, N.; Campbell, C.; Fan, X.; Dikiy, S.; van der Veeken, J.; deRoos, P.; Liu, H.; Cross, J. R.; Pfeffer, K.; Coffer, P. J.; et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504, 451-455.
86. Ames, B. N.; Gold, L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990, 249, 970-971.
87. Cohen, S. M.; Ellwein, L. B. Cell proliferation in carcinogenesis. Science 1990, 249, 1007-1011.
88. Shaffer, A. L.; Rosenwald, A.; Staudt, L. M. Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2002, 2, 920-932.
89. Pasqualucci, L.; Neumeister, P.; Goossens, T.; Nanjangud, G.; Chaganti, R. S. K.; Kuppers, R.; Dalla-Favera, R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001, 412, 341-346.
90. Oliver, A. M.; Martin, F.; Kearney, J. F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 1999, 162, 7198-7207.
91. Kullisaar, T.; Zilmer, M.; Mikelsaar, M.; Vihalemm, T.; Annuk, H.; Kairane, C.; Kilk, A. Two antioxidative lactobacilli strains as promising probiotics. Int. J. Food Microbiol. 2002, 72, 215-224.
92. Federico, A.; Morgillo, F.; Tuccillo, C.; Ciardiello, F.; Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer. 2007, 121, 2381-2386.
93. Epeldegui, M.; Widney, D. P.; Martinez-Maza, O. Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions. Curr. Opin. Oncol. 2006, 18, 444-448.
94. Illes, A.; Varoczy, L.; Papp, G.; Wilson, P. C.; Alex, P.; Jonsson, R.; Kovacs, T.; Konttinen, Y. T.; Zeher, M.; Nakken, B.; Szodoray, P. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy. Scand. J. Immunol. 2009, 69, 387-400.
95. Al-Saleem, T.; Al-Mondhiry, H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 2005, 105, 2274-2280.
96. Lecuit, M.; Abachin, E.; Martin, A.; Poyart, C.; Pochart, P.; Suarez, F.; Bengoufa, D.; Feuillard, J.; Lavergne, A.; Gordon, J. I.; et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 2004, 350, 239-248.
97. Ferreri, A. J.; Guidoboni, M.; Ponzoni, M.; de Conciliis, C.; Dell'Oro, S.; Fleischhauer, K.; Caggiari, L.; Lettini, A. A.; Clin, E. D.; Leri, R.; et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J. Natl. Cancer Inst. 2004, 96, 586-594.